Haisco Pharmaceutical Group Co Ltd saw a significant surge in its stock price, rising over 7%, as the company and its peers in the innovative drug sector experienced notable market activity and investor interest.

Haisco Pharmaceutical Group Co Ltd is a prominent player in the Chinese pharmaceutical sector, specializing in developing and manufacturing innovative drugs, with a promising outlook and recent market trends suggesting continued growth.

Haisco Pharmaceutical Group Co Ltd is making strategic moves to drive growth, including governance restructuring, innovation, and market expansion, positioning itself for sustained success in the competitive healthcare landscape.